{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:06:40Z","timestamp":1786115200035,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006128","name":"Swedish Order of Freemasons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010761","name":"Swedish Association for Allergology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008352","name":"The Samariten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016290","name":"Insamlingsstiftelsen Cancer- och Allergifonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010234","name":"Asthma and Allergy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009757","name":"HKH Crown Princess Lovisa Child Health Care Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["Dnr 2020-01839"],"award-info":[{"award-number":["Dnr 2020-01839"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023--02616"],"award-info":[{"award-number":["2023--02616"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["FoUI-961605"],"award-info":[{"award-number":["FoUI-961605"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["FoUI-973325"],"award-info":[{"award-number":["FoUI-973325"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013493","name":"Ellen Walter and Lennart Hesselman Foundation for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lanepe.2026.101690","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:16:20Z","timestamp":1778109380000},"page":"101690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and efficiency of peanut oral immunotherapy in preschool children with slow up-dosing and low maintenance dosing: a randomised controlled trial"],"prefix":"10.1016","volume":"66","author":[{"given":"Susanna","family":"Klevebro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5454-4105","authenticated-orcid":false,"given":"Carina","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Roald","family":"Konradsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0996-4773","authenticated-orcid":false,"given":"Josefin","family":"Ullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Ganrud","family":"Tedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idun","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Badolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-872X","authenticated-orcid":false,"given":"Rui","family":"Da Silva Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-8681","authenticated-orcid":false,"given":"Eva","family":"Sverremark-Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Asarnoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lanepe.2026.101690_bib1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1159\/000516811","article-title":"Natural course and prognostic factors of immediate-type peanut allergy in children","volume":"182","author":"Jung","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101690_bib2","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/all.16129","article-title":"Immunotherapy and biologics in the management of IgE-mediated food allergy: systematic review and meta-analyses of efficacy and safety","volume":"79","author":"Riggioni","year":"2024","journal-title":"Allergy"},{"issue":"10322","key":"10.1016\/j.lanepe.2026.101690_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the immune tolerance network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101690_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101690_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/all.15027","article-title":"Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy","volume":"77","author":"Fernandez-Rivas","year":"2022","journal-title":"Allergy"},{"issue":"10207","key":"10.1016\/j.lanepe.2026.101690_bib6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lanepe.2026.101690_bib7","first-page":"1","article-title":"Efficacy and safety of oral immunotherapy for peanut allergy: a GRADE-assessed systematic review and meta analysis of randomised controlled trials","author":"Khan","year":"2025","journal-title":"Int Arch Allergy Immunol"},{"issue":"21","key":"10.1016\/j.lanepe.2026.101690_bib8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"PALISADE Group of Clinical Investigators","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101690_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-019-56961-3","article-title":"Adverse events associated with peanut oral immunotherapy in children - a systematic review and meta-analysis","volume":"10","author":"Grzeskowiak","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101690_bib10","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101690_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaip.2020.10.045","article-title":"First real-world effectiveness analysis of preschool peanut oral immunotherapy","volume":"9","author":"Soller","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101690_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300145","article-title":"Oral immunotherapy for peanut allergy in children 1 to less than 4 years of age","volume":"2","author":"Du Toit","year":"2023","journal-title":"NEJM Evid"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101690_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cea.70126","article-title":"Pragmatic low-dose oral immunotherapy for preschool children with peanut allergy: a randomised controlled trial","volume":"55","author":"O\u2019Sullivan","year":"2025","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101690_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101690_bib15","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaci.2021.12.780","article-title":"Safety of peanut (Arachis hypogaea) allergen powder-DNFP in children and teenagers with peanut allergy: pooled summary of phase 3 and extension trials","volume":"149","author":"Brown","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101690_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2352-4642(20)30234-0","article-title":"Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"4","author":"O'B Hourihane","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101690_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.alit.2020.03.008","article-title":"Slow low-dose oral immunotherapy: threshold and immunological change","volume":"69","author":"Sugiura","year":"2020","journal-title":"Allergol Int"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101690_bib18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/cea.13022","article-title":"Is a slow-progression baked milk protocol of oral immunotherapy always a safe option for children with cow's milk allergy? A randomized controlled trial","volume":"47","author":"Amat","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101690_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy-real-life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101690_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/all.16027","article-title":"Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force","volume":"79","author":"Rodr\u00edguez Del R\u00edo","year":"2024","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101690_bib21","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaip.2024.02.030","article-title":"High degree of desensitization after 1 year of early-life peanut oral immunotherapy: small children Oral Immunotherapy (SmaChO) randomized controlled trial","volume":"12","author":"Uhl","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101690_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/cea.13824","article-title":"Mechanisms of oral immunotherapy","volume":"51","author":"Barshow","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101690_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2019.10.038","article-title":"Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE","volume":"145","author":"Tsai","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101690_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cea.14320","article-title":"Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol","volume":"53","author":"Uhl","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101690_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2008.08.039","article-title":"Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy","volume":"122","author":"Du Toit","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101690_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/all.15165","article-title":"Development and validation of the food allergy severity score","volume":"77","author":"Fern\u00e1ndez-Rivas","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101690_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1710-1492-10-11","article-title":"Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy","volume":"10","author":"Sudo","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101690_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/cea.14400","article-title":"Effectiveness and safety of low-dose oral immunotherapy protocols in paediatric milk and egg allergy","volume":"53","author":"Miyaji","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101690_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101690_bib30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jaci.2017.09.034","article-title":"Allergen specificity of early peanut consumption and effect on development of allergic disease in the learning early about peanut allergy study cohort","volume":"141","author":"du Toit","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101690_bib31","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/all.15834","article-title":"A comparison of double-blind, placebo-controlled food challenge and open food challenge","volume":"78","author":"Jessen","year":"2023","journal-title":"Allergy"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622600102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622600102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:58:13Z","timestamp":1785977893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266677622600102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S266677622600102X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101690","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficiency of peanut oral immunotherapy in preschool children with slow up-dosing and low maintenance dosing: a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101690"}}